Adenosinergic inhibition in hippocampus is mediated by adenosine A1 receptors very similar to those of peripheral tissues.

[1]  J. Palacios,et al.  Autoradiographic Visualization of A1 Adenosine Receptors in Rat Brain with [3H]8‐Cyclopentyl‐1,3‐Dipropylxanthine , 1990, Journal of neurochemistry.

[2]  T. Dunwiddie,et al.  In vivo pertussis toxin treatment attenuates some, but not all, adenosine A1 effects in slices of the rat hippocampus. , 1989, European journal of pharmacology.

[3]  P. Worley,et al.  Intrahippocampal injection of pertussis toxin blocks adenosine suppression of synaptic responses , 1989, Brain Research.

[4]  C. Alzheimer,et al.  Transient and selective blockade of adenosine A1-receptors by 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) causes sustained epileptiform activity in hippocampal CA3 neurons of guinea pigs , 1989, Neuroscience Letters.

[5]  T. Dunwiddie,et al.  Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus. , 1989, The Journal of pharmacology and experimental therapeutics.

[6]  B. Fredholm,et al.  Evidence that prejunctional adenosine receptors regulating acetylcholine release from rat hippocampal slices are linked to an N-ethylmaleimide-sensitive G-protein, but not to adenylate cyclase or dihydropyridine-sensitive Ca2+-channels. , 1988, Acta physiologica Scandinavica.

[7]  T. Dunwiddie,et al.  Pre- and postsynaptic actions of adenosine in the in vitro rat hippocampus , 1987, Brain Research.

[8]  C. Allgaier,et al.  The adenosine receptor‐mediated inhibition of noradrenaline release possibly involves a N‐protein and is increased by α2‐autoreceptor blockade , 1987, British journal of pharmacology.

[9]  G. Lu,et al.  Adenosine Receptor Subtypes: Binding Studies , 1987 .

[10]  J. Ribeiro,et al.  Adenosine receptors and calcium: Basis for proposing a third (A3) adenosine receptor , 1986, Progress in Neurobiology.

[11]  Ching M. Wang,et al.  Adenosine inhibits epileptiform activity arising in hippocampal area CA3 , 1986, British journal of pharmacology.

[12]  R. Delorenzo,et al.  A new class of adenosine receptors in brain. Characterization by 2-chloro[3H]adenosine binding. , 1986, Biochemical pharmacology.

[13]  H. Haas,et al.  Adenosine actions on CA1 pyramidal neurones in rat hippocampal slices. , 1985, The Journal of physiology.

[14]  A. Dolphin,et al.  Pertussis toxin reverses adenosine inhibition of neuronal glutamate release , 1985, Nature.

[15]  T. Dunwiddie.  The physiological role of adenosine in the central nervous system. , 1985, International review of neurobiology.

[16]  R. Corradetti,et al.  Adenosine decreases aspartate and glutamate release from rat hippocampal slices. , 1984, European journal of pharmacology.

[17]  B. Fredholm,et al.  Levels of adenosine and adenine nucleotides in slices of rat hippocampus , 1984, Brain Research.

[18]  G. Kreutzberg,et al.  Regulation of the strength of adenosine modulation in the hippocampus by a differential distribution of the density of A1 receptors , 1983, Brain Research.

[19]  M. Reddington,et al.  An A1-adenosine receptor, characterized by [3H]cyclohexyladenosine binding, mediates the depression of evoked potentials in a rat hippocampal slice preparation , 1982, Neuroscience Letters.